Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > More Insider activity.

<< Previous

Bullboard Posts

Next >>

Comment by laroplexon Dec 21, 2024 10:25am

171 Views

Post# 36373531

RE:RE:More Insider activity.

Canadafan that is great for you, increase your share count another 30%....To be honest i've been doing the same, regaedless of my venting the other day....I got lucky i was able to pick some more up at $1.04 on Thursday around 10'ish in the morning...then BOOM, she went upward hard and fast, deep pocket buying.....I got my even low single 6 digit amount of shares....Now it's a waiting game for me(which i'm immune to).....Looking forward to 2025....GLTA

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season